1. Home
  2. KMDA vs SEAT Comparison

KMDA vs SEAT Comparison

Compare KMDA & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • SEAT
  • Stock Information
  • Founded
  • KMDA 1990
  • SEAT 2001
  • Country
  • KMDA Israel
  • SEAT United States
  • Employees
  • KMDA N/A
  • SEAT N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • KMDA Health Care
  • SEAT Industrials
  • Exchange
  • KMDA Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • KMDA 380.7M
  • SEAT 366.2M
  • IPO Year
  • KMDA N/A
  • SEAT N/A
  • Fundamental
  • Price
  • KMDA $6.89
  • SEAT $2.08
  • Analyst Decision
  • KMDA Strong Buy
  • SEAT Buy
  • Analyst Count
  • KMDA 3
  • SEAT 11
  • Target Price
  • KMDA $14.67
  • SEAT $4.49
  • AVG Volume (30 Days)
  • KMDA 53.8K
  • SEAT 2.6M
  • Earning Date
  • KMDA 05-14-2025
  • SEAT 05-06-2025
  • Dividend Yield
  • KMDA 2.89%
  • SEAT N/A
  • EPS Growth
  • KMDA 66.67
  • SEAT N/A
  • EPS
  • KMDA 0.25
  • SEAT N/A
  • Revenue
  • KMDA $160,953,000.00
  • SEAT $748,757,000.00
  • Revenue This Year
  • KMDA $14.01
  • SEAT N/A
  • Revenue Next Year
  • KMDA $9.24
  • SEAT $5.90
  • P/E Ratio
  • KMDA $27.37
  • SEAT N/A
  • Revenue Growth
  • KMDA 12.93
  • SEAT 0.82
  • 52 Week Low
  • KMDA $4.74
  • SEAT $1.66
  • 52 Week High
  • KMDA $9.15
  • SEAT $5.90
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 58.32
  • SEAT 40.02
  • Support Level
  • KMDA $6.69
  • SEAT $2.65
  • Resistance Level
  • KMDA $7.10
  • SEAT $1.90
  • Average True Range (ATR)
  • KMDA 0.16
  • SEAT 0.18
  • MACD
  • KMDA 0.05
  • SEAT -0.05
  • Stochastic Oscillator
  • KMDA 72.00
  • SEAT 31.11

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: